James Leal - May 25, 2023 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Chief Manufacturing Officer
Signature
/s/ Rachel Malina, Attorney-in-Fact for James A. Leal
Stock symbol
TNDM
Transactions as of
May 25, 2023
Transactions value $
-$3,401
Form type
4
Date filed
5/30/2023, 09:25 PM
Previous filing
May 17, 2023
Next filing
Aug 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +309 +3.67% $0.00 8.72K May 30, 2023 Direct
transaction TNDM Common Stock Tax liability -$3.4K -128 -1.47% $26.57 8.6K May 30, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM RSU 2023 05 25 Award $0 +17.2K $0.00 17.2K May 25, 2023 Common Stock 17.2K $0.00 Direct F2, F3, F4
transaction TNDM Restricted Stock Unit Options Exercise $0 -309 -19.96% $0.00 1.24K May 30, 2023 Common Stock 309 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2 Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
F3 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F4 RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
F5 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
F6 RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.